Health Care

UnitedHealth on Tuesday posted a strong earnings beat as revenue continued to surge in its pharmacy-services business and the biggest U.S. health insurer lifted the low end of its guidance for year.

As the GOP descends upon Cleveland for the Republican National Convention, the region’s economy is taking a pause.

It's been more than six years since the Affordable Care Act, aka ObamaCare, was signed into law.

Before leaving the workforce, take these steps to smooth your transition to freedom.

New York City's health department on Friday reported the first female-to-male transmission of the Zika virus, which is most typically spread by the bite of an infected mosquito.

Herbalife Ltd. is to pay $200 million in a settlement with the Federal Trade Commission that will enable the company to avoid being classified as a pyramid scheme, a victory in its long-running battle with activist investor William Ackman.

A federal judge on Thursday scheduled a trial for June 2017 in the U.S. government's securities fraud case against former pharmaceutical executive Martin Shkreli, who became a lightning rod last year for criticism of soaring prescription drug prices.

Germany's Bayer AG made a revised takeover bid for Monsanto Co. after previous attempts to seal the mega deal were rebuffed.

President Barack Obama, reviewing his signature health law six years into its implementation, is suggesting Congress and his White House successor add a government-run, or public, insurance option to the Affordable Care Act and increase federal financial assistance for people to buy coverage.

The U.S. is trying to shut down an estimated 17,000 illegal farms in South Korea that raise dogs for their meat.

The U.S. is trying to shut down an estimated 17,000 illegal farms in South Korea that raise dogs for their meat.

Johnson & Johnson said it would cut up to 6% of its workforce in its medical-devices division as part of an effort to cut $1 billion in annual costs.

Valeant Pharmaceuticals is under investigation by the SEC.

Pfizeron Tuesday said its Wyeth unit agreed to pay $784.6 million to settle claims over Medicaid rebates, prompting the drug giant to revise its fourth-quarter results downward.

Pfizer on Monday unveiled its slate of executives who will run the combined company after it closes its roughly $150 billion inversion deal to buy Allergan.

Merck posted declines in sales and profit as the pharmaceutical giant gave revenue projections below analyst forecasts and earnings expectations on the lower end of them.

Valeant Pharmaceuticals International filed its overdue annual report on Friday morning, likely resolving the looming danger of debt default for the Canadian company.

Valeant Pharmaceuticals International on Thursday said it secured a commitment from loan holders to amend terms of its debt, buying time as the drugmaker attempts to resuscitate itself.

A day after the Obama administration limited the ability of U.S. companies to do international deals to lighten their tax burdens, Pfizer and Allergan terminated their planned $150 billion merger and other companies around the globe raced to assess the impact of the new rules.

Allergan announced plans Tuesday to streamline its executive team under Chief Executive Brent Saunders and buy back up to $10 billion in stock as the drugmaker reported sales that fell short of analysts' expectations.